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2Introduction
Antibiotics are the most powerful tools we have to fight life-threatening 
infections, like those that can lead to sepsis. However, anytime 
antibiotics are used, they can cause side effects and contribute to 
antibiotic resistance. The Centers for Disease Control and Prevention 
(CDC) is working to promote appropriate use by helping prescribers use 
the right antibiotic, at the right dose, for the right duration, and at the 
right time, and reduce unnecessary antibiotic use.
Improving the way we prescribe and use antibiotics, or “antibiotic 
stewardship,” is critical to effectively treat infections, protect patients 
from harms caused by unnecessary antibiotic use, and combat 
antibiotic resistance. The United States has made some progress in 
improving antibiotic prescribing and use in human health, but many 
opportunities remain. 
In 2017, CDC released “Antibiotic Use in the United States, 2017: 
Progress and Opportunities,” which included information about 
antibiotic use in healthcare settings and highlighted programs and 
resources to support stewardship. 
The report also demonstrates the specific roles and actions for:
 ■ healthcare providers
 ■ patients and their families
 ■ health systems, hospitals, 
and clinics
 ■ nursing homes
 ■ healthcare quality 
organizations
 ■ health insurance companies
 ■ healthcare provider 
professional organizations
 ■ federal, state, and local 
health agencies
This 2018 update highlights new antibiotic stewardship data, programs, 
and resources since the July 2017 report. CDC continues to work 
to improve antibiotic prescribing and use through data for action, 
implementation, innovation, and education. 
In U.S. Doctor ’s Offices and Emergency Departments
70%
of antibiotic prescriptions
are likely necessary.
(Improvement still needed in 
drug selection, dose and duration)
30%
of antibiotic prescriptions 
are unnecessary.
At least
In 2016, Congress recognized 
the urgent need to combat 
antibiotic resistance and 
appropriated financial resources 
for CDC to implement the  
Antibiotic Resistance 
Solutions Initiative,  
which is improving the  
United States’ capacity to:
Detect, respond to, and 
contain emerging resistance . 
Prevent and stop  
spread of resistant 
 infections in healthcare  
and community settings . 
Improve  
antibiotic use .
3Data for Action
One of the most important ways CDC helps improve antibiotic use is producing and analyzing 
data to support healthcare facilities and providers in making the best choices for their 
patients. Healthcare facilities, providers, health departments, and other partners can use 
these data to identify opportunities to improve antibiotic stewardship efforts. 
2016 Outpatient Antibiotic Prescribing Data 
Too many antibiotics are prescribed unnecessarily in the United States. CDC estimates about 
47 million antibiotic courses each year are prescribed for infections that don’t need antibiotics 
in U.S. doctors’ offices and emergency departments each year. That’s about 30% of all 
antibiotics prescribed. 
Antibiotic prescribing nationally has improved, with a 5% decrease from 2011 to 2016, but 
more progress needs to be made. In 2016, 270.2 million antibiotic prescriptions were written 
in the United States. That’s enough antibiotic courses for five out of every six Americans  
(on average) to receive an antibiotic prescription. Prescribing rates vary by state, with a  
2.5-fold difference between the lowest and prescribing states, suggesting there are 
opportunities for improvement. 
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42017 Hospital Antibiotic Stewardship Program Data
The number of hospitals that reported having an antibiotic stewardship 
program meeting all seven of CDC’s Core Elements of Hospital 
Antibiotic Stewardship Programs almost doubled from 2014 to 2017. 
Of the 4,992 acute care hospitals responding to the 2017 National 
Healthcare Safety Network (NHSN) Annual Hospital Survey, 3,816 
(76.4%) reported uptake of all seven Core Elements. This increase 
is likely driven by a number of factors, including new accreditation 
requirements for hospitals.
CDC is working with accreditation organizations to improve assessment 
of the quality of antibiotic stewardship programs. The national goal is 
100% by 2020.
Percentage of Hospitals Meeting all 7 Core Elements, by State —2017
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Core Elements of Antibiotic 
Stewardship for Hospitals
Leadership Commitment 
Dedicating necessary human, financial, 
and information technology resources.
Accountability
Appointing a single leader 
responsible for program outcomes.
Drug Expertise
Appointing a single pharmacist leader 
responsible for working to improve 
antibiotic use.
Action
Implementing at least one recommended 
action, such as systemic evaluation of 
ongoing treatment need after a set period 
of initial treatment.
Tracking
Monitoring antibiotic prescribing 
and resistance patterns.
Reporting
Regular reporting information on 
antibiotic use and resistance to doctors, 
nurses, and relevant staff.
Education 
Educating clinicians about resistance  
and optimal prescribing.
5Opportunities to Improve Antibiotic Use
While progress has been made to improve antibiotic use, there is still more work to be done. 
CDC studies show that, across all healthcare settings, antibiotics are being prescribed 
for illnesses that don’t require antibiotics. The studies also show that when antibiotics are 
required to treat infections, the wrong antibiotic type, dose, and duration are often prescribed. 
Improving antibiotic use is important to effectively treat infections, protect patients from 
harms caused by unnecessary antibiotic use, and combat antibiotic resistance, one of the 
most urgent threats to the public’s health. 
Antibiotics are often unnecessarily prescribed for common respiratory 
conditions in outpatient settings .
“Comparison of Antibiotic Prescribing in Retail Clinics, Urgent Care Centers, 
Emergency Departments, and Traditional Ambulatory Care Settings in the United 
States,” published in The Journal of the American Medical Association: Internal Medicine in 
July 2018, found that healthcare providers in outpatient settings often prescribed antibiotics 
for respiratory illnesses for which antibiotics are not needed, such as the common cold and 
bronchitis. Four outpatient settings were studied: 
 ■ urgent care centers
 ■ emergency departments (EDs)
 ■ retail health clinics 
 ■ traditional medical offices 
Healthcare providers in urgent care centers prescribed antibiotics unnecessarily for 
respiratory illnesses that don’t require antibiotics 46% of the time, compared to 25% in EDs, 
17% in medical offices, and 14% in retail health clinics. Urgent care centers also had the 
highest percentage of all visits that led to an antibiotic prescription. 
Based on these new data representing all outpatient visits, unnecessary antibiotic prescribing 
in the United States could be higher than the previously estimated 30% reported in a 2016 
study, “Prevalence of Inappropriate Antibiotic Prescriptions Among U.S. Ambulatory 
Care Visits, 2010–2011.”
CDC is actively collaborating with organizations in the  
urgent care space to identify successes, challenges, and  
opportunities for improvement related to antibiotic use.
The Urgent Care Association (UCA), the largest urgent care professional 
organization, is incorporating antibiotic stewardship as an essential 
component of any UCA-accredited organization’s quality plan.
6Percent of Visits for Respiratory Illnesses With an Unnecessary Antibiotic Prescription
Urgent
Care
Emergency
Department
Medical
Office
Retail
Health Clinic
46%
25%
17% 14%
Fluoroquinolones are unnecessarily prescribed for urinary tract 
infections and respiratory conditions .
“Opportunities to Improve Fluoroquinolone Prescribing in the United States for Adult 
Ambulatory Care Visits,” published in Clinical Infectious Diseases in January 2018, reported 
that about 5% of all fluoroquinolone antibiotics prescribed for adults in medical offices and 
EDs in 2014 were unnecessary. This study also reported that about 20% of all fluoroquinolone 
prescriptions in these two settings were not the recommended first-line treatment. Nearly 32 
million fluoroquinolone prescriptions were dispensed from U.S. outpatient pharmacies. 
Fluoroquinolones are not the recommended first-line treatment for urinary tract infections 
(UTIs) or sinusitis, but these conditions accounted for an estimated 6.3 million prescriptions 
in 2014. Fluoroquinolones were the most commonly prescribed antibiotic for UTIs. Colds 
and bronchitis, which should not be treated with antibiotics, led to an estimated 1.6 million 
unnecessary fluoroquinolone prescriptions in medical offices and EDs in 2014. 
Fluoroquinolones can cause disabling and potentially permanent side effects, including 
damage to tendons, muscles, joints, nerves, and the central nervous system. Fluoroquinolone 
use can also lead to life-threatening Clostridioides difficile (C. difficile) infection, which 
causes diarrhea that can lead to severe colon damage and death.
CDC Commentary: 
Thinking of a Fluoroquinolone? Think Again 
View this video on Medscape [4:38] 
Summary of CDC study published in Clinical Infectious Diseases that provides 
data on fluoroquinolone prescribing and use, and information on why appropriate 
fluoroquinolone prescribing is an important patient safety issue.
7In 2016, the Food and Drug Administration (FDA) issued a warning advising healthcare 
providers to use fluoroquinolones only for patients with conditions for which no alternative, 
effective treatment options are available. In December 2018, FDA issued another warning 
about fluoroquinolone use due to the increased risk of ruptures or tears in the aorta blood 
vessel in certain patients. 
Nearly 70% of antibiotic courses for sinus infections were longer than 
recommended .
“Antibiotic Therapy Duration in U.S. Adults With Sinusitis,” published in The Journal 
of the American Medical Association: Internal Medicine in July 2018, reports that primary 
care physicians are prescribing longer durations of antibiotics for sinus infections than 
recommended by clinical practice guidelines. 
A key antibiotic stewardship principle is to use the shortest, most effective length of antibiotic 
treatment recommended by guidelines. 
This 2018 study also reports that nearly 70% of antibiotic prescriptions were for 10 days or 
longer. Yet the Infectious Diseases Society of America guidelines recommend treating 
adults with uncomplicated sinus infections with five to seven days of antibiotics, when 
antibiotics are needed for sinus infections. “Uncomplicated” means that the patient: 
 ■ is at low risk of developing an antibiotic-resistant infection
 ■ does not have any signs that the infection is spreading beyond the sinuses
 ■ starts getting better in the first few days with antibiotics
Guidelines recommend five to seven days  
of antibiotic treatment for most sinus infections in adults. 
However, almost 70% of antibiotic prescriptions  
for sinus infections are for 10 days.
  
 
5-7 
days 
  
 
5-7 
days 
8Five days of azithromycin use accounted for more than 20% of antibiotics prescribed for 
sinus infections. However, treatment guidelines recommend against prescribing azithromycin 
due to high rates of existing resistance to this drug and others in its class. 
As noted in a 2016 study, “Prevalence of Inappropriate Antibiotic Prescriptions among 
US Ambulatory Care Visits, 2010–2011,” antibiotics are prescribed for sinus infections more 
than any other illness in outpatient settings. 
Improvement is needed in antibiotic selection in children . 
“Variations in Antibiotic and Azithromycin Prescribing for Children by Geography and 
Specialty—United States, 2013,” a CDC study released in the Pediatric Infectious Disease 
Journal in January 2018, found that azithromycin, a commonly prescribed antibiotic in 
children, is often prescribed when it’s not recommended or not the recommended first-line 
drug by clinical guidelines. The study also found that when antibiotics were prescribed, family 
practitioners were more likely to choose azithromycin than pediatricians. 
In 2013, nearly 67 million antibiotics were prescribed to children younger than 19, the 
most common of which were amoxicillin (35%) and azithromycin (18%). Amoxicillin is a 
recommended first-line antibiotic for many common illnesses in children, including ear 
infections, sinus infections, and strep throat. But azithromycin, with a few exceptions, is not 
a recommended treatment for common pediatric infections. This misuse of azithromycin is 
concerning because patients might not be receiving the best therapy, and it contributes to 
antibiotic resistance. 
Antibiotic prescribing for all agents (A) and azithromycin prescribing (B)  
per 1000 children ≤ 19 years of age by state—United States, 2013
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9Antibiotic duration is too long in adult hospitalized patients with 
community-acquired pneumonia . 
“Duration of Antibiotic Use Among Adults With Uncomplicated Community-Acquired 
Pneumonia Requiring Hospitalization in the United States,” published in Clinical Infectious 
Diseases in April 2018, reported that antibiotic therapy was too long—just under 10 days—
for 70% of adult patients hospitalized for community-acquired pneumonia. Previous studies 
have suggested that length of antibiotic treatment for community-acquired pneumonia often 
exceeds national recommendations and represents an important opportunity to improve 
antibiotic use nationally. 
In 2007, the Infectious Diseases Society of America and the American Thoracic 
Society published national guidelines for treatment of community-acquired pneumonia, 
recommending a minimum of five days of therapy, with seven or more days rarely necessary. 
Better adherence to recommended community-acquired pneumonia treatment guidelines, 
including recommended duration of therapy at hospital discharge, is an important target for 
antibiotic stewardship programs.
Most adults patients need five days of antibiotic therapy  
for community-acquired pneumonia.  
However, 70% of adult patients hospitalized for  
community-acquired pneumonia receive  
almost 10 days of therapy.
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CDC Efforts to Improve Antibiotic Use
CDC uses data to guide efforts to promote appropriate use when antibiotics are needed and 
reduce unnecessary antibiotic use. To accelerate improvements, support innovation, and 
help healthcare facilities and providers make the best decisions to treat and protect their 
patients, CDC provides technical expertise and tools for implementation, data for action, and 
educational resources.
Evidence and Tools for Implementation: CDC’s Core Elements of Antibiotic Stewardship 
provide frameworks for antibiotic stewardship programs and practices in outpatient settings, 
nursing homes, and hospitals, including small hospitals in rural areas. 
CDC works with public health and healthcare partners, including health systems, hospital 
associations, professional organizations, academic investigators, private industry, patient and 
consumer organizations, state and local health departments, and federal partners to promote 
and facilitate implementation of the Core Elements and explore new ways to improve use.
Measuring Antibiotic Use in Healthcare: One of the most important ways CDC helps 
improve antibiotic use is producing and analyzing data to support healthcare facilities and 
providers in making the best choices for their patients. Healthcare facilities can use these data 
to identify opportunities to ensure appropriate antibiotic use, assess the impact of antibiotic 
stewardship efforts, and improve patient care. For example, hospitals participating in CDC’s 
NHSN Antibiotic Use Option can compare their antibiotic use to others, monitor use over 
time, and use the data to direct hospital antibiotic stewardship programs. CDC is working with 
partners in all settings to identify, track, and understand antibiotic use data to use these data 
for improvement. 
Education: CDC is also educating healthcare providers and the public 
about the importance of improving antibiotic use. Be Antibiotics Aware 
aims to raise awareness about antibiotic resistance and the importance 
of appropriate antibiotic prescribing and use. Get Ahead of Sepsis 
emphasizes the importance of sepsis early recognition, timely treatment, 
and reassessment of antibiotic therapy, as well as the importance of 
preventing infections that can lead to sepsis. Together, these two educational efforts promote 
the importance of integrating antibiotic stewardship efforts with sepsis management.
Promoting appropriate antibiotic use in sepsis management: When sepsis is suspected, 
it’s critical to start antibiotics as soon as possible. An important component of antibiotic 
stewardship in sepsis care is to reassess antibiotic therapy to stop or change therapy as 
needed, based on patients’ clinical condition and culture results. This ensures patients are 
treated with the right antibiotic, at the right dose, for the right duration, and at the right time. 
CDC is encouraging hospitals to integrate antibiotic stewardship efforts with sepsis 
management and ensuring that sepsis work at CDC is integrated with overall plans for 
combating antibiotic resistance. CDC and partners recently conducted the first assessment of 
national sepsis burden among adults that was based on electronic medical records, identified 
factors that put children and adults at higher risk for sepsis, and is now field testing tools to 
help healthcare facilities track sepsis. Additionally, CDC is collaborating with partners, clinical 
organizations, and consumer groups to implement sepsis awareness efforts and improve 
antibiotic prescribing and use.
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Antibiotic-related Adverse Drug Events Data 
Anytime antibiotics are used, they can cause side effects. Healthcare providers should 
carefully weigh the risks and benefits of prescribing an antibiotic and discuss these risks and 
common side effects with patients. Side effects can include rash, dizziness, nausea, diarrhea, 
and yeast infections, but also more serious conditions like C. difficile infection and severe or 
life-threatening allergic reactions.
Antibiotic-related adverse drug events (ADEs) are a common cause of 
adult emergency department visits . 
“National Estimates of Emergency Department Visits for Antibiotic Adverse Events 
Among Adults—United States, 2011–2015,” published in the Journal of General Internal 
Medicine in April 2018, reveals that antibiotic-related adverse drug events (ADEs) led to 
145,000 adult ED visits in the United States each year from 2011 to 2015. Young adults 
(20–34 years) visited the ED for antibiotic-related ADEs from oral antibiotics twice as often as 
older adults (≥ 65 years). 
Antibiotics save lives and are critical tools for treating infections, 
like those that can lead to sepsis, but they can lead to adverse  
drug events. Healthcare providers, parents, and caregivers  
should minimize unnecessary antibiotic use to reduce allergic  
reactions and other ADEs—this is the best way to protect  
children from these risks, including severe allergic reactions.
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Optimize Antibiotic Prescribing and Use to Reduce ADEs in Children .
In children, antibiotics are the leading cause of ED visits for ADEs, according to “U.S. 
Emergency Department Visits for Adverse Drug Events from Antibiotics in Children, 
2011–2015,” published in the Journal of the Pediatric Infectious Diseases Society in August 
2018. The study estimates that from 2011 to 2015, 70,000 children 19 years or younger 
visited the ED for antibiotic-related ADEs each year. Many of these visits (41%) were from 
children 2 years or younger. Most visits (86%) involved allergic reactions, such as rash, 
pruritus (itching), and angioedema (severe swelling beneath the skin).
Rates of ED Visits for ADEs from Common Oral Antibiotics  
in Children <19 Years Old—U .S ., 2011-2015
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New CDC Antibiotic Stewardship Resources
CDC develops tools to help U.S. and international healthcare facilities and providers 
implement antibiotic stewardship activities. When antibiotic stewardship programs and 
practices are adopted, patients receive the best antibiotic treatment.
Online antibiotic stewardship training offers free continuing education 
for healthcare providers . 
In 2018, CDC released a four-section online antibiotic stewardship training course for 
healthcare providers. The course offers up to eight hours of continuing education (CE) and 
covers various topics related to appropriate antibiotic prescribing practices and antibiotic 
resistance, including:
 ■ Section 1: Antibiotic resistance and the benefits of antibiotic stewardship 
 ■ Section 2: Antibiotic stewardship in outpatient settings
 ■ Section 3: Antibiotic stewardship considerations for the management of common 
outpatient conditions and dentistry
 ■ Section 4: Antibiotic stewardship in emergency departments, hospitals, and  
nursing homes
While this course is primarily for healthcare providers who prescribe antibiotics, CDC 
recognizes that everyone plays an important role in improving antibiotic use. This course is 
open to:
 ■ physicians
 ■ nurse practitioners
 ■ physician assistants
 ■ certified health education specialists
 ■ nurses
 ■ pharmacists
 ■ public health practitioners with a master’s degree in public health
This course fulfills Improvement Activities (IA) Patient Safety and Practice Assessment (PSPA) 
23 and PSPA_24 under the Centers for Medicare & Medicaid Services (CMS) Merit-Based 
Incentive Programs, or MIPS.
14
CDC’s new Core Elements aims to help resource-
limited settings improve antibiotic use . 
In September 2018, CDC released Core Elements of Human 
Antibiotic Stewardship Programs in Resource-Limited Settings: 
National and Hospital Levels, a guide for antibiotic stewardship 
program implementation in resource-limited settings that have fragile 
health systems and lack robust, regulatory frameworks. 
Implementing stewardship programs in resource-limited settings is 
challenging for a variety of reasons. One main reason is that most 
antibiotic stewardship guidance is for high-resource settings. This 
new guide provides practical, high-impact stewardship strategies 
for resource-limited settings to improve antibiotic use and combat 
antibiotic resistance. 
The guide discusses national-level policies and programs grouped by 
capacity and the resources needed to ensure that they are feasible and 
sustainable. National-level activities are a critical complement to the 
activities undertaken in hospitals and other healthcare facilities. At the 
facility level, the guide presents a practical, stepwise framework for 
acute care facilities to develop antibiotic stewardship programs. 
Many resource-limited settings face challenges in implementing all 
antibiotic stewardship activities recommended by global or local public 
health agencies—but meaningful steps are possible in any setting. 
While the Core Elements are not an exhaustive list of approaches, they 
serve as a starting point for stakeholders. 
This guide builds off the Core 
Elements resource originally created 
for U.S. healthcare settings to 
outline structures and functions 
associated with effective programs: 
 ■ Core Elements of Hospital 
Antibiotic Stewardship 
Programs
 ■ The Core Elements of 
Outpatient Stewardship
 ■ The Core Elements of 
Antibiotic Stewardship for 
Nursing Homes
 ■ Implementation of Antibiotic 
Stewardship Core Elements 
for Small and Critical Access 
Hospitals
15
CDC sepsis surveillance toolkit helps healthcare 
facilities track sepsis and improve antibiotic 
treatment in sepsis . 
In 2018, CDC released the Hospital Toolkit for Adult Sepsis 
Surveillance, which provides healthcare facilities with tools 
to assess adult sepsis incidence and monitor progress in their 
facilities. The toolkit enables healthcare professionals to track 
facility-level sepsis incidence and outcomes using surveillance 
methodology from “Incidence and Trends of Sepsis in U.S. 
Hospitals Using Clinical vs. Claims Data, 2009–2014,” published in the Journal of the 
American Medical Association in October 2017. Data are useful for understanding the 
effectiveness of local sepsis prevention, early recognition, and treatment programs.
Antibiotic stewardship programs and sepsis care programs in facilities should be coordinated 
because prompt use of antibiotics is a critical component of sepsis care. Antibiotics should 
be started as soon as sepsis is suspected. A critical step in treatment is to review antibiotic 
therapy 48 to 72 hours after it is started to stop, change, or continue therapy based on 
the patient’s clinical condition and microbiology culture results. This toolkit can be used in 
hospital quality-improvement efforts, particularly in identifying antibiotics used in sepsis, so 
hospitals can facilitate both rapid administration and appropriate de-escalation of antibiotics 
in sepsis to improve patient care. 
Antibiotic Stewardship in Action
CDC collaborates with partners to implement activities to improve antibiotic use at a local 
level. Healthcare facilities and organizations across the country are implementing targeted 
antibiotic stewardship improvements in outpatient, inpatient, and long-term care settings. 
Partner Outpatient Antibiotic Stewardship Efforts 
The American Academy of Pediatrics (AAP) implements antibiotic 
stewardship through a chapter Quality Network Project.
AAP worked with 14 pediatric practices in Virginia, through a chapter Quality Network project, 
on the Judicious Use of Antibiotics Pilot Project. They utilized CDC’s Core Elements of 
Outpatient Antibiotic Stewardship and quality improvement methods to decrease antibiotic 
prescriptions for children with viral upper respiratory infections (URIs), and prescribe more 
appropriately for bacterial ear infections, sinusitis, and pharyngitis. Activities also focused on 
educating parents, caregivers, and families about antibiotics. 
Hospital 
Toolkit 
for Adult Sepsis Surveillance
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Teams used quality improvement methods to integrate best practices gradually into their 
workflows and policies, and to change physician behaviors and beliefs about antibiotic use. 
Participants held in-person meetings and monthly webinars to share what they learned and 
review practice-level data to facilitate cross-practice learning and accelerate adoption of best 
practices. Here are the activities the practices implemented, with their results:
 ■ Increased first-line antibiotic prescribing.
 ● Prescriptions for first-line antibiotics increased from 63.5% to 79.3% by the end 
of the project. This was excellent performance, given that roughly 10% of children 
have a reported history of penicillin allergy and another 10% likely had taken a 
penicillin-based antibiotic in the previous four to six weeks. 
 ■ Decreased prescription fill rates for acute otitis media (AOM) through use of delayed 
prescribing, or safety-net antibiotic prescriptions (SNAPs).
 ● The proportion of AOM prescriptions written as SNAPs increased from 4.5% at 
baseline to 24.5% after six months. 
 ■ Increased education provided to families about antibiotics and symptom management.
 ● At the start of this project, only about half of all practices documented regular AOM 
and URI education. 
 ● Education for URI during visits increased from 66.1% to 86.7%. 
 ● Education for AOM symptom management during visits and/or delayed prescribing 
increased from 19.7% to 86.3%.
Although 10% of the U.S. population reports a penicillin allergy, fewer than  
1% are truly penicillin allergic. Correctly identifying if patients are penicillin-
allergic can decrease the unnecessary use of broad-spectrum antibiotics. 
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The Quality Innovation Network-Quality Improvement Organizations successfully 
implements CDC’s Core Elements of Outpatient Antibiotic Stewardship. 
The Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs), funded 
by the Centers for Medicare & Medicaid Services (CMS), are working with 7,629 outpatient 
facilities across the country to implement CDC’s Core Elements of Outpatient Antibiotic 
Stewardship. The QIN-QIOs targeted the following outpatient facilities: 
 ■ physician offices
 ■ outpatient pharmacies and clinics
 ■ EDs
 ■ urgent care clinics
 ■ Federally Qualified Health Centers (FQHCs)
As of August 5, 2018, over 5,100 outpatient facilities across the country were implementing 
all four Core Elements. Additionally, a Field Guide to Outpatient Antibiotic Stewardship 
provides a collection of concrete implementation strategies, suggestions, and tools designed, 
tested, and applied by QIN-QIOs. 
Below are some examples of individual QIN-QIOs successfully implementing the  
Core Elements:
HealthCentric Advisors QIN (Maine QIN-QIO) is hosting webinars throughout the region. 
One webinar highlighted how a physician and pharmacist worked with their team to reduce 
antibiotic prescribing for acute bronchitis in outpatient offices from 35% to 0% in one year. In 
another webinar, Dr. Elizabeth Dennis shared how her initiative was able to reduce antibiotic 
prescribing from 84% to 8% in the outpatient setting and 67% to 54% in the ED by giving 
“goody bags” with self-care items, such as tissues and cough drops, and information about 
bronchitis to patients with acute bronchitis. 
Health Services Advisory Group (HSAG) QIN (Ohio QIN-QIO) is sharing antibiotic use data 
and treatment recommendations with providers to improve antibiotic prescribing. HSAG 
created a custom high-performer and low-performer accountability document based on a 
provider-level antibiotic prescribing report and shared with target providers. Letters were sent 
to each department medical director outlining the growing threat of antibiotic resistance and 
high antibiotic prescribing rates in their county (based on Medicare Part D claims information). 
The letter provided an overall antibiotic-use metric for the providers in the health system, 
an acceptable rate based on National Quality Forum (NQF)’s 0058 Avoidance of Antibiotic 
Treatment in Adults with Acute Bronchitis, and a timeframe for correction. 
Following the letter, the system infectious disease physician and chief clinical pharmacist 
performed site visits that included question-and-answer sessions with providers. During these 
meetings, they showed providers their specific antibiotic prescribing information (privately) 
and gave them time to ask questions. Providers were also given an opportunity to review the 
method behind the data abstraction. Each provider was given the system-wide outpatient 
antibiogram (antibiotic susceptibility profiles for specific bacteria), contact information for 
patient treatment questions/concerns, and facility-specific treatment recommendations for 
common outpatient diagnoses, based on national standards and local resistance patterns. 
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Site visits and outreach are ongoing, but the initial provider and facility feedback has been 
extremely positive. To ensure sustainability of this project, HSAG is providing technical 
support to staff in participating health systems so they can generate their own antibiotic 
prescribing reports going forward.
Great Plains QIN (South Dakota QIN-QIO) is providing facilities with additional support 
for antibiotic stewardship. Great Plains connected facilities with Johns Hopkins University 
stewardship experts to provide additional support for antibiotic stewardship activities. 
Interested facilities submitted 10 patient cases for the experts to review and recommend 
changes in care or treatment. 
Atlantic Quality QIN (New York QIN-QIO) creates a duration-of-therapy pocket guide 
to reduce lengthy antibiotic therapy. These pocket guides were created after site-
specific reports demonstrated lengthy durations of therapy of targeted antibiotics (i.e., 
fluoroquinolones, amoxicillin-clavulanate, cephalosporins). They distributed a county-level 
antibiogram of isolates from urine specimens tested at Quest Diagnostics to recruited sites to 
inform providers about local resistance patterns to assist in the selection of empiric antibiotic 
therapy for cystitis.
HSAG QIN (Arizona QIN-QIO) is raising awareness about improving antibiotic 
prescribing and use among Hispanic populations. HSAG developed a relationship with 
the Arizona chapter of the National Hispanic Nurses Association. The chapter president is 
collaborating with a physician to discuss antibiotic use on Spanish-language radio to increase 
awareness, understand barriers, and reach a broader audience.
Partner Inpatient Antibiotic Stewardship Efforts
A Colorado Hospital Association collaborative is improving diagnosis and 
management of urinary tract infections and skin and soft tissue infections. 
In partnership with the Colorado Hospital Association, Colorado hospitals were invited to 
participate in the Acute Care Antimicrobial Stewardship Collaborative to improve the 
diagnosis and management of inpatient urinary tract infections (UTIs) and skin and soft 
tissue infections. Twenty-six hospitals, including nine critical access hospitals, participated 
in the collaborative. Significant reductions were observed in the use of fluoroquinolones for 
UTIs, use of broad-spectrum antibiotics for skin infections, and treatment durations for skin 
infections. 
A number of hospitals achieved significant improvements from the collaborative, particularly 
the critical access hospitals. This project demonstrates that the collaborative model is a 
feasible approach to engage a large number of diverse hospitals in a common antibiotic 
stewardship intervention. 
Physicians and pharmacists at Atrium Health partner across a large footprint  
to establish an antibiotic stewardship program. 
Atrium Health, a Charlotte, NC-based integrated healthcare system with more than 40 
hospitals and 12.5 million annual patient encounters, established a formalized antibiotic 
stewardship program in 2013 with the launch of its Antibiotic Support Network (ASN).  
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The ASN is a network of pharmacists and physicians who advise medical and pharmacy staff 
on the optimal selection, dosage, and duration of antibiotic therapy. 
Building on the success of the ASN, Atrium Health formed a collaborative in 2016 to expand 
stewardship beyond the Charlotte area and encompass 28 acute care hospitals of varying 
size and scope across the Carolinas (i.e., critical access to tertiary care). The collaborative 
succeeds with a pharmacist and physician-led quality advisory team, who combine 
their expertise with the efforts of local champions (administrative staff, physicians, and 
pharmacists) that facilitate each location’s customized, daily stewardship activities. 
Antibiotic stewardship efforts across the system’s acute care hospitals yielded aggregate 
reductions of 15% to 20% in broad-spectrum antibiotic use. Working across the care 
continuum, Atrium Health has also formed an outpatient antibiotic stewardship program 
and launched a marketing and communications campaign, Got Germs?, with educational 
resources for patients, consumers, and providers about appropriate use of antibiotics in 
outpatient settings.
Partner Long-term Care Antibiotic Stewardship Efforts 
The Rochester Nursing Home Collaborative implements antibiotic stewardship 
programs to reduce the use of fluoroquinolones. 
The Rochester Nursing Home Collaborative is a collaboration between the University of 
Rochester Medical Center antibiotic stewardship team and 10 nursing homes in Monroe 
County, NY. CDC’s Core Elements of Antibiotic Stewardship for Nursing Homes served 
as a framework for implementing antibiotic stewardship programs at participating nursing 
homes. The collaborative succeeded in reducing the use of fluoroquinolones over a five-year 
period across several nursing homes. This success is attributed to the following activities:
 ■ Developing and disseminating local treatment guidelines to healthcare  
providers. An advisory group of nursing home medical directors developed and 
disseminated local treatment guidelines for common infections to nursing home  
staff and prescribers. 
 ■ Tracking antibiotic use data to identify improvement opportunities. The 
stewardship teams at the nursing homes were provided with quarterly antibiotic use 
reports to identify targets for improving use and track the progress of stewardship 
interventions (e.g., percentage of antibiotic orders with documented indications, 
proportion of residents on prophylaxis for UTI, proportion of fluoroquinolones 
prescribed for specific conditions).
 ■ Providing antibiotic stewardship education to healthcare providers, patients, 
and their families. Medical and nursing staff were provided in-person antibiotic 
stewardship education. Also, informational pamphlets about the principals of  
antibiotic stewardship and appropriate treatment for UTIs were distributed to  
residents and families.
20
The Minnesota Department of Health (MDH) provides 
tools, education, and recognition to nursing homes.
In 2017 and 2018, MDH supported antibiotic stewardship in nursing 
homes with new tools, educational opportunities, and statewide 
recognition. In many nursing homes, competing priorities make 
stewardship education and implementation difficult, so MDH developed 
the Minnesota Sample Antibiotic Stewardship Policy for Long-Term 
Care Facilities and companion guide. Facilities use these documents 
to identify and document how CDC’s Core Elements of Antibiotic 
Stewardship for Nursing Homes will be implemented in their setting. 
MDH has also used an Antibiotic Stewardship Policy Writing  
Workshop to provide both education on the Core Elements and 
dedicated time for stewardship leaders to draft a stewardship policy  
for their nursing homes. Online long-term care stewardship  
education is also available.
The Minnesota Antibiotic Stewardship Honor Roll for Long-Term 
Care, hosted by MDH, recognizes antibiotic stewardship commitment, 
action, and collaboration in Minnesota nursing homes and shares 
facility approaches on a website.
Minnesota’s One Health Antibiotic 
Stewardship Collaborative provides 
an environment to promote judicious 
use of antibiotics and combat antibiotic 
resistance in humans, animals, and the 
environment. 
Its goals are to: 
Promote understanding  
of the One Health approach  
across disciplines
Improve human and animal 
antibiotic stewardship efforts
Communicate the impact of 
antibiotic use in the environment
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